Postmenopausal and steroid-induced osteoporosis. Guideline-orientated prevention and treatment;Postmenopausale und kortikoidinduzierte osteoporose. Leitliniengerechte prophylaxe und therapie

Internist

Volumn 46, Issue SUPPL. 1, 2005, Pages

  Pfeilschifter, J ^a  

^a Evangelisches Krankenhaus Lutherhaus   (Germany)

Author keywords

Bone mineral density; Falls; Fractures; Glucocorticoids; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; GLUCOCORTICOID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; STEROID; STRONTIUM RANELATE; VITAMIN D;

BONE DENSITY; CALORIC INTAKE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; COORDINATION; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIET SUPPLEMENTATION; FALLING; FRAGILITY FRACTURE; HUMAN; LONG TERM CARE; MUSCLE EXERCISE; MUSCLE STRENGTH; POSTMENOPAUSE; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY OSTEOPOROSIS; VITAMIN SUPPLEMENTATION;

CALCIUM; EXERCISE THERAPY; FEMALE; GERMANY; GLUCOCORTICOIDS; HORMONE REPLACEMENT THERAPY; HUMANS; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 21244434796     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-005-1411-z     Document Type: Conference Paper

References (19)

1. Banks E, Beral V, Reeves G, Balkwill A, Barnes I; Million Women Study Collaborators (2004) Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA 291:2212-2220
2. Bauer DC, Ettinger B, Nevitt MC, Stone KL (2001) Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann intern Med 134:561-568
3. Bischoff-Ferrari HA, Dawson-Hughes B, WillettWC et al. (2004) Effect of Vitamin D on falls: a meta-analysis. JAMA 291:1999-2006
4. Bonaiuti D, Shea B, lovine R et al. (2002) Exercise for preventing and treating osteoporosis in postmenopausal women (Cochrane Review). Cochrane Database Syst Rev:CD000333
5. Chang JT, Morton SC, Rubenstein LZ et al. (2004) Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ 328:680-687
6. Chapuy MC, Arlot ME, Duboeuf F et al. (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637-1642
7. Cranney A, Waldegger L, Zytaruk N et al. (2003). Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database Syst Rev CD004523
8. Cranney A, Wells G, Willian A et al. (2002) Meta-analysis of alendronate fort he treatment of postmenopausal women. Endocrine Rev 23:508-516
9. Cranney A, Tugwell P, Zytaruk N et al. (2002) Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocrine Rev 23:524-528
10. Ensrud KE, Ewing SK, Stone KL, Cauley JA, Bowman PJ, Cummings SR;The Study of Osteoporotic Fractures Research Group (2003) Intentional and Unintentional Weight Loss Increase Bone Loss and Hip Fracture Risk in Older Women. J Am Geriatr Soc. 51:1740-1747
11. Holick MF (1996) Vitamin D and bone health. J Nutr 126(4 Suppl):1159S-1164S
12. Meunier PJ, Roux C, Seeman E et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459-4168
13. Neer RM, Arnaud CD, Zanchetta JR et al. (2001 ) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
14. Parker MJ, Gillespie LD, Gillespie WJ (2003) Hip protectors for preventing hip fractures in the elderly. Cochrane Database Syst Rev CD001255
15. Pfeifer M, Begerow B, Minne HW (2004) Effects of a new spinal orthosis on posture, trunk strength, and quality of life in women with postmenopausal osteoporosis: a randomized trial. Am J Phys Med Rehabil. 83:177-186
16. Sarkar S, Reginster JY, Crans GG, Diez-Perez A, Pinette KV, Delmas PD (2004) Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture Risk. J Bone Miner Res 19:394-401
17. Schoofs MW, Klift M van der, Hofman A et al. (2003) Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 139:476-482
18. Wallace BA, Cumming RG (2000) Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 67:10-18
19. Watts NB, Cooper C, Lindsay R et al. (2004) Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom 7:255-261